Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

New number of shares and votes in Dustin Group AB (publ)

The long-term incentive program for senior executives introduced at an extraordinary general meeting on January 30, 2015, entitles the holder of warrants to subscribe for new shares in the company during the first half of 2018. In February 2018, a total of 231,313 shares have been issued through the exercise of warrants received from the incentive program. Prior to the issue of the new shares, there were 76,173,115 shares and votes in the company. As of February 28, 2018, there are a total of 76,404,428 shares and votes in the company. For further information, please contact: Eva

Insider transaction in Episurf Medical

Board member Laura Shunk has on 27 February 2018 bought 5,000 shares in Episurf Medical. Laura Shunk now owns 15,750 Class B-shares. For more  information, please contact: Pål Ryfors, CEO, Episurf Medical Tel:+46 (0) 709 62 36 69 Email: pal.ryfors@episurf.com About Episurf Medical Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for

Moberg Pharma divests Balmex® for $4.25 million

STOCKHOLM, February 28th 2018, Moberg Pharma AB (OMX: MOB) has entered into an agreement with Randob Labs to divest the brand Balmex® for a total consideration of $4.25 million (34.6 million SEK) plus the inventory value at closing. The divestment is expected to result in a capital gain of circa $0.5 million (4.4 million SEK), enabling Moberg Pharma to further focus resources on its larger brands.The brand Balmex®, with a number of products for treating and preventing diaper rash, was acquired from Chattem Inc. in April, 2015. The role of Balmex® in the product portfolio has reduced after

Erik Fällström lends shares in Sivers IMA Holding AB in connection with the previously announced directed share issue

In connection with the directed share issue announced by Sivers IMA Holding AB on February 23 this year, the company’s shareholder (via holding company) Erik Fällström lends 4,400,000 shares to Erik Penser Bank to facilitate delivery of the corresponding number of shares subscribed for in the share issue. The borrowed shares will be returned when the share issue has been registered with the Swedish Company Registration Office (Bolagsverket).Sivers IMA Holding AB announced on February 23, that Swedbank Robur and Nordic Cross had subscribed for in total 4.4 million shares in the company for a

Biohit Group Financial Statement Release 2017

Biohit Oyj Financial Statement Release, 28 February 2018 at 9:30 am local time (EET) SUMMARY January-December 2017 · Net sales grew by 9.6 % compared to 2016 · Net sales EUR 9.0 million (EUR 8.2 million) · EBITDA EUR 7.9. million (EUR -3.0 million) · Operative EBITDA EUR -0.4 million (EUR -1.9 million) · Operating profit EUR 6.4 million (EUR -3.4 million) · The profit for the reporting period was EUR 6.1 million (EUR -3.3 million) · Net sales from international operations 95.7 % (92.2 %) of total net sales · Equity ratio 91.3 % (83.0 %) July-December 2017

Respiratorius presents positive results from clinical studies of VAL001

Respiratorius reports positive results from clinical phase I/IIa studies of VAL001.The key results from the Phase I / IIa studies are presented briefly: · •       Published scientific results from the Phase I study show a potential synergistic effect with Rituximab as VAL001 increases the levels of the surface protein CD20. · •       Overall Survival Analysis for 32 patients treated with VAL001 and R-CHOP shows that 1-year survival is 100% and 2-year survival is 96.8%. Comparative data from a matched reference population of 330 patients from The Swedish lymphoma registry treated

Increased number of shares and votes in Catena Media plc

The number of shares and votes in Catena Media plc amounts to 54,391,469 shares and votes following a directed share issue of 385,924 shares.Catena Media has, as announced on 7 February 2018, resolved on a directed share issue of 385,924 shares as payment of part of the purchase price for acquired assets in Dreamworx Online Ltd. The share issue has been registered with Maltese authorities in February 2018. Subsequent to the share issue, the number of shares and votes in Catena Media has increased from 54,005,545 to 54,391,469 and the share capital has increased to EUR 81,587.2035. For

Standard & Poor’s Ratings Services upgraded Metsä Board Corporation to investment grade

Metsä Board Corporation Stock Exchange Release 28 February 2018 at 9.15 am EETStandard & Poor’s Ratings Services has upgraded Metsä Board Corporation's issuer credit rating to investment grade, from BB+ to BBB-. The outlook of the rating is stable. The upgrade reflects Metsä Board’s strong performance in 2017 and the expectation of strong cash flows in the coming years. The stability of Metsä Board’s business operations is supported by solid and long-lasting customer relationships as well as the strong market position. At the same time, Standard & Poor’s raises the ratings of Metsä

Etrion to Speak at SpareBank 2018 Energy Conference

February 28, 2018, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, announces that the Company’s CEO, Marco A. Northland, will be speaking at the SpareBank 2018 Energy Conference in Oslo on Thursday, March 1, 2018, at 2:45 pm Central European Time. A copy of the presentation will be available on Etrion’s website at www.etrion.com  About Etrion Etrion Corporation is an independent power producer that develops, builds, owns and operates utility-scale solar power generation plants. The Company owns and

Elite Asset Management Plc's financial statements bulletin for 2017 - Group's comparable net sales increased 18%, Alfred Berg integration proceeding as planned

Elite Asset Management Plc, Company Announcement, 28 February 2018, 9:00 a.m. (EET) Elite Asset Management Plc's financial statements bulletin for 2017 - Group's comparable net sales increased 18%, Alfred Berg integration proceeding as planned Elite group's ('Group') January-December 2017 in brief (comparison with the 1-12/2016 financial year, figures are audited) · Comparable net sales* grew by 18% to exceed €16 million. · Operating profit before depreciation decreased by 15% to approximately €1.1 million. · Profit for the financial year grew by 120% to some €1.3 million.

DDM Debt AB: Q4 and full year report January - December 2017

Significant increase in portfolio value and substantial financing raisedHighlights fourth quarter 2017 · Second Croatian investment of EUR 21M finalized, following regulatory approval  · New partner and co-investor in Greece, reducing DDM’s investment by about EUR 15M · Entered Serbia, investing EUR 2M · Equity injection of EUR 10M from DDM Finance AB · EUR 50M of senior secured bonds at 8% issued and listed on Nasdaq Stockholm to support continued strong growth · Net collections increased by 181% to EUR 12.6M (Q4 2016: EUR 4.5M) · Cash EBITDA increased by 162% to EUR

DDM Holding AG: Q4 and full year report January - December 2017

Significant increase in portfolio value and substantial financing raisedHighlights fourth quarter 2017 · Second Croatian investment of EUR 21M finalized, following regulatory approval · New partner and co-investor in Greece, reducing DDM’s investment by about EUR 15M · Entered Serbia, investing EUR 2M · EUR 10M bridge financing raised · EUR 50M of senior secured bonds at 8% issued and listed on Nasdaq Stockholm to support continued strong growth  · Gross ERC at the end of December 2017 was EUR 250M, a significant increase of 213% (Q4 2016: EUR 80M) · Net collections

Agromino A/S: 4Q 2017 Interim Financial Report

Highlights  ·  Overall the business turned to a net profit of EUR 3.5 million for 2017 from a net loss of EUR 25.1 million in 2016 ·  Lower financial costs by EUR 5.0 million ·  Share of profit EUR 1.5 million from investments in shares of TDFE against a loss of EUR 1.4 million in 2016, note that this is a non-cash item as dividends are not paid at present ·  No loss from discontinued operations for 2017 against a loss of EUR 23.5 million in 2016 ·  2017 EBITDA of EUR 5.5 million against EUR 4.7 million in 2016 ·  Summer crop yields reduced by drought and high

Year End Report 2017

Full year   · Throughout 2017 the Group has been moving forward with its SEK 30 million capital investment in the Hob Certec ceramic roller business in the Czech Republic. This significant investment will position the Group to meet demand from the market for even longer rollers, keeping us right at the forefront of the market and significantly expanding capacity from previous levels.  After the completion of final testing, the Group has made its first sales of product manufactured in the new kiln in early 2018. · The Group completed a strategic refinancing during 2017 and repaid

Essity restructures in Chile

Essity is restructuring its production facility in Santiago, Chile, to further improve quality and cost for the Consumer Tissue and Professional Hygiene businesses in the country. These measures are aligned with the company’s strategy to optimize the production footprint to increase cost and capital efficiency and further increase value creation in the Consumer Tissue and Professional Hygiene business areas.The restructuring measures include the closure of one tissue machine and two converting lines. The restructuring costs amount to approximately SEK 140m, and will be recognized as an

Klarna year-end report January - December 2017

Our purpose at Klarna is to simplify buying. This is done by making buying simpler and safer for consumers and selling simpler and safer for merchants. Klarna’s business is primarily comprised of payment solutions and consumer credit products designed specifically for e-commerce. Today, Klarna’s services have expanded beyond traditional e-commerce, for example, by managing payments for public transport, media and increasingly in physical stores. Klarna receives revenues from both the merchants and the consumers that use Klarna’s payment solutions.July - December 2017● Compared to last

Read original

NEW REIMBURSEMENT SYSTEM IN POLAND

The Polish National Health Fund (Narodowy Fundusz Zdrowia, NFZ) is now implementing its new reimbursement system and this will result in changes to our contracts with effect from 31 March. Medicover will no longer provide NFZ services of Cardiac Surgery Care and some general services, but our Cardiology and ICU (Intensive Care Unit) contracts are still under consideration of NFZ in terms of opening tender procedures. In 2017, all contracts with NFZ accounted for 1.5% of total revenue for Medicover and 3.1% for Healthcare Services’ revenue. The contracts that end on 31 March correspond to

IRRAS strengthens executive team with appointment of Kellie Fontes as Senior Director of Human Capital

San Diego, California, Stockholm, Sweden, February 28, 2018 – IRRAS (NASDAQ STOCKHOLM: IRRAS), a commercial-stage medical technology company developing breakthrough devices for a broad range of intracranial bleeding applications and procedures, today announced the appointment of Kellie Fontes as Senior Director, Human Capital and a member of the executive management team. Ms Fontes brings nearly 30 years of experience and knowledge in all facets of Human Resources. Ms Fontes will report directly to the President CEO of IRRAS, Kleanthis G. Xanthopoulos, Ph.D., from the San Diego site in

DOME ENERGY PRESENTS INTERIM REPORT FOR JULY-DECEMBER 2017

SECOND HALF-YEAR   · Revenue from oil & gas production incl. realized derivatives $4,245’ (2,458’). · Effect from unrealized derivatives of - $338’ (0). · Gross result from production incl. realized derivatives $1,511’ (867’) with a margin of 36% (35%). · EBITDA of -$839’ (-1,574’). · EBITDA for US operations adj. for unrealized derivatives amounted -$9’ (- 1,431’). If adjusted for non-cash items and one-off events it equals $776’. · Net result of $20,543’ (13,239’). · Earnings per share $0.09 (0.38). FULL YEAR   · Revenue from oil & gas production incl.

Resurs Bank intends to carry out an intra-group cross-border merger with yA Bank AS

The Board of Directors of Resurs Bank AB (publ) (“Resurs Bank”) announces its intention to initiate a process to merge Resurs Bank with its wholly-owned subsidiary yA Bank AS (“yA Bank”), by a cross-border merger. The intention is to complete the merger during 2018. Resurs Bank is expecting the proposed merger to enable a more effective utilization of internal resources and knowledge transfer, a broader product offering under the trademark Resurs and optimization of capital and liquidity utilization within the Resurs Group. Completion of the merger entails that the regulatory capital

Resurs Bank intends to carry out an intra-group cross-border merger with yA Bank AS

The Board of Directors of Resurs Bank AB (publ) (“Resurs Bank”), a wholly-owned subsidiary to Resurs Holding AB (publ), announces its intention to initiate a process to merge Resurs Bank with its wholly-owned subsidiary yA Bank AS (“yA Bank”), by a cross-border merger. The intention is to complete the merger during 2018. Resurs Bank is expecting the proposed merger to enable a more effective utilization of internal resources and knowledge transfer, a broader product offering under the trademark Resurs and optimization of capital and liquidity utilization within the Resurs Holding Group.

Displaced Iraqis forced to return to destruction left in wake of war on IS group

Displaced face desolation, reprisal and even death in home areas, others have no home to return toBAGHDAD – The majority of Iraqis currently displaced in Anbar by the war against the Islamic State group (IS) feel safer in camps than back home aid agencies warned today, amid moves by Iraqi authorities to return thousands of families to their places of origin, at times with fatal consequences. “It’s tragic to think that people feel safer in camps than in their homes when this conflict has supposedly ended,” said Country Director of the Norwegian Refugee Council (NRC) in Iraq, Petr

ZINZINO AB (PUBL): STRONG GROWTH AND PROPOSAL FOR GREATLY INCREASED DIVIDENDS

Interim Report Q4 - 2017The fourth quarter can be characterised by continued strong growth in the Swedish domestic market. Growth also continued in Finland and Germany, and there has been an increase in customers in Latvia and Lithuania. The quarter has also been characterized by investments concerning the shift to digital - new platforms, internet and e-commerce – that are now starting to show positive effects and will support increased efficiency, sales growth and new market launches in the coming years. The product segment Zinzino Health increased by 17% in the fourth quarter and

Polygiene AB (publ.) Year-End Release 1 January–31 December 2017

Tough end of the year but with zero earnings in the quarterQ4 in brief · Net revenue decreased by 2.1% (7.5% after foreign exchange effects) in Q4, and amounted to MSEK 19.8 (20.2). Net revenue was MSEK 75.7 (61.6) for the full year. · The operating profit before taxes for the period was MSEK 0.0 (0.6) · The adjusted operating profit was MSEK 0.6 (1.1) for the quarter, after unrealized currency effects and with-holding tax. · The fixed costs have decreased by 11% compared to the corresponding quarter last year. · The cash flow for Q4 was MSEK -4.5 (-6.0). · The company’s

There are no items matching the current filter
There are no more items matching the current filter
Back to top